n of 1: One man's Harvard-documented remission of incurable cancer using only natural methods
Twenty-five years ago my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story . . .



In 1991, Glenn Sabin was a twenty-eight-year-old newlywed diagnosed with chronic lymphocytic leukemia (CLL)-a disease doctors called "uniformly fatal." Treatments could buy him some time and eventually ease his discomfort, but there was no conventional cure. Glenn's prognosis was clear: he was going to die.



Although Glenn and his wife, Linda, continued to consult with doctors, cancer specialists and top oncologists, Glenn made a monumental decision: he would become his own health advocate. While he continued to "watch and wait," Glenn would figure out how to stay alive.



No one could predict when a large-scale clinical trial would discover a cure for CLL, so Glenn began his own, medically monitored and carefully researched lifestyle changes. He would conduct his own, single patient clinical trial.



He would become an "n of 1."



Today, Glenn is not only alive, but a 2012 biopsy at Harvard confirmed that his bone marrow contains no leukemic cells. His case is now part of the medical literature.
"1124916527"
n of 1: One man's Harvard-documented remission of incurable cancer using only natural methods
Twenty-five years ago my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story . . .



In 1991, Glenn Sabin was a twenty-eight-year-old newlywed diagnosed with chronic lymphocytic leukemia (CLL)-a disease doctors called "uniformly fatal." Treatments could buy him some time and eventually ease his discomfort, but there was no conventional cure. Glenn's prognosis was clear: he was going to die.



Although Glenn and his wife, Linda, continued to consult with doctors, cancer specialists and top oncologists, Glenn made a monumental decision: he would become his own health advocate. While he continued to "watch and wait," Glenn would figure out how to stay alive.



No one could predict when a large-scale clinical trial would discover a cure for CLL, so Glenn began his own, medically monitored and carefully researched lifestyle changes. He would conduct his own, single patient clinical trial.



He would become an "n of 1."



Today, Glenn is not only alive, but a 2012 biopsy at Harvard confirmed that his bone marrow contains no leukemic cells. His case is now part of the medical literature.
12.99 In Stock
n of 1: One man's Harvard-documented remission of incurable cancer using only natural methods

n of 1: One man's Harvard-documented remission of incurable cancer using only natural methods

by Glenn Sabin, Dawn Lemanne MD

Narrated by Charles Constant

Unabridged — 4 hours, 6 minutes

n of 1: One man's Harvard-documented remission of incurable cancer using only natural methods

n of 1: One man's Harvard-documented remission of incurable cancer using only natural methods

by Glenn Sabin, Dawn Lemanne MD

Narrated by Charles Constant

Unabridged — 4 hours, 6 minutes

Audiobook (Digital)

$12.99
FREE With a B&N Audiobooks Subscription | Cancel Anytime
$0.00

Free with a B&N Audiobooks Subscription | Cancel Anytime

START FREE TRIAL

Already Subscribed? 

Sign in to Your BN.com Account


Listen on the free Barnes & Noble NOOK app


Related collections and offers

FREE

with a B&N Audiobooks Subscription

Or Pay $12.99

Overview

Twenty-five years ago my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story . . .



In 1991, Glenn Sabin was a twenty-eight-year-old newlywed diagnosed with chronic lymphocytic leukemia (CLL)-a disease doctors called "uniformly fatal." Treatments could buy him some time and eventually ease his discomfort, but there was no conventional cure. Glenn's prognosis was clear: he was going to die.



Although Glenn and his wife, Linda, continued to consult with doctors, cancer specialists and top oncologists, Glenn made a monumental decision: he would become his own health advocate. While he continued to "watch and wait," Glenn would figure out how to stay alive.



No one could predict when a large-scale clinical trial would discover a cure for CLL, so Glenn began his own, medically monitored and carefully researched lifestyle changes. He would conduct his own, single patient clinical trial.



He would become an "n of 1."



Today, Glenn is not only alive, but a 2012 biopsy at Harvard confirmed that his bone marrow contains no leukemic cells. His case is now part of the medical literature.

Editorial Reviews

From the Publisher

"When I first met Glenn 10 years ago, he told me he was going to beat his chronic lymphocytic leukemia. Since then I have followed his activity and daily regimen, and indeed, he has been extremely successful. Is he an outlier or is his regimen worth studying on a larger scale?"

David S. Rosenthal, MD Professor of Medicine, Harvard Medical School Henry K. Oliver Professor of Hygiene (Emeritus), Harvard University Past president, American Cancer Society

"A remarkable story of self-efficacy and pure grit. Glenn is a poster child for evidence-based integrative oncology and an exemplar of what might be achieved for others. I highly recommend this book."

Mark Hyman, MD Director, Cleveland Clinic Center for Functional Medicine, and 10-time #1 New York Times bestselling author

"n of 1 should be required reading for all cancer patients, but especially anyone who has received a dire prognosis. Glenn's determination, careful research, and willingness to change allowed him to find a cure for his "fatal" cancer, and we all have much to learn from his incredible experience."

Kelly Turner, MD New York Times Bestselling author of Radical Remission: Surviving Cancer Against All Odds

"I heard Glenn speak at UCSD and was captivated. A special story about resiliency and self-efficacy that resonates far and wide!"

T. Colin Campbell, PhD Bestselling author of The China Study Jacob Gould Schurman Professor Emeritus of Nutritional Biochemistry, Cornell University

"We need to understand that self-induced healing is an entity. It is not a spontaneous remission. We all need to learn from those who don't die when doctors expect them to. Glenn's experience and book will help you to understand and to achieve what is involved in survival behavior."

Bernie Siegel, MD Author of Love, Medicine & Miracles and The Art of Healing

"How do we maintain a rigorous, scientific, yet open mind when it comes to discovery in medicine? In n of 1, Glenn Sabin reminds us that every observation is important-to be woven into the rubric of knowledge so that we may heal with collective experience."

Debu Tripathy, MD Professor and Chair, Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center

"A riveting account of one man's journey in fighting his cancer successfully with an unconventional approach. Thought-provoking!"

Gary Deng, MD, PhD Memorial Sloan-Kettering Cancer Center

"Glenn Sabin appears to be one of those few remarkable, determined individuals who become sufficiently involved in their self-healing to overcome a medically "incurable" cancer. Medical science needs to shake off its materialistic bias and study this phenomenon seriously, so that "n of 1" can become "n of many."

Alastair Cunningham, OC, PhD Professor Emeritus of Medical Biophysics at University of Toronto Author of Can the Mind Heal Cancer?

"Spirited and moving, n of 1 teaches us so much about hope, resolve, and resilience in the face of cancer."

Jun J. Mao, MD MSCE Laurance S. Rockefeller Chair in Integrative Medicine Chief, Integrative Medicine Service Memorial Sloan-Kettering Cancer Center

"n of 1 is the amazing tale of Glenn Sabin's resilience in the face of adversity, and is motivation for us all. A moving testament of how a positive attitude plus a healthy lifestyle can have a profound impact on one's life".

Neal Barnard, MD President, Physicians Committee for Responsible Medicine

Product Details

BN ID: 2940177273112
Publisher: Tantor Audio
Publication date: 05/26/2020
Edition description: Unabridged
Sales rank: 998,952
From the B&N Reads Blog

Customer Reviews